Get started
Author

Sjoerd J. F. Hermans

Observed names: Hermans, Sjoerd, Hermans, Sjoerd J F, S.J.F. Hermans, Sjoerd Hermans, Sjoerd J.F. Hermans
ORCID: 0000-0002-3906-4584
Observed ORCID: 0000-0002-3906-4584
OpenAlex ID: A5075940556
Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
2018 · Zhen Ping, Si Chen, et al. · Leukemia · 44
PDF
Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers
2024 · Sjoerd J. F. Hermans, Niek G. van der Maas, et al. · JAMA Oncology · 15
PDF
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis
2023 · Sjoerd J. F. Hermans, Jurjen Versluis, et al. · HemaSphere · 12
Real-time data in cancer registries: Validation of an automated data extraction system
2025 · Sylvie A.M. Langhout, Sjoerd J.F. Hermans, et al. · iScience · 5
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi‐state modeling
2024 · Sjoerd J. F. Hermans, Yvette van Norden, et al. · Cancer Medicine · 3
PDF
Comparability of external and internal control patients for the prospective randomized HOVON ‐103 trial in older AML patients
2025 · Sjoerd J. F. Hermans, Jurjen Versluis, et al. · British Journal of Haematology · 1
PDF
Outcome of Intensively Treated Elderly AML Patients Reported to the Harmony Alliance Compares Well to Outcome of Control Patients of the Prospective Randomized HOVON 103 Study in Elderly AML
2023 · Sjoerd J.F. Hermans, Jurjen Versluis, et al. · Blood · 1
PDF
P565: Real-world Data as Supplementary Controls for the Prospective Randomized Hovon-103 Trial in Intensively Treated Elderly Acute Myeloid Leukemia Patients
2023 · Sjoerd Hermans, Yvette van Norden, et al. · HemaSphere · 1
T-cell prolymphocytic leukemia presenting as ascites
2019 · Sjoerd J. F. Hermans, Yorick Sandberg · Blood · 1
Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia
2026 · S.J.F. Hermans, J. Versluis, et al. · ESMO Real World Data and Digital Oncology
Introducing real-world data and multi-state modeling in clinical trials in acute Leukemia:Benefits and risks
2026 · Hermans, Sjoerd · EUR Research Repository (Erasmus University Rotterdam)
Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin
2026 · Dimitrios Kotsos, Patrycja Gradowska, et al. · Haematologica
PDF
Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin.
2026 · Kotsos, Dimitrios, Gradowska, Patrycja, et al. · Open Access CRIS of the University of Bern
The HOVON 100 Study in Adult Acute Lymphoblastic Leukemia Re-Analysed By Multi-State Modeling: Benefits and Risks of Clofarabine
2022 · Sjoerd J.F. Hermans, Yvette Norden, et al. · Blood
Works count: 14
Citation count: 83
H-index: 4
I10-index: 3
Year
Topic
Type